Circulating microRNAs in obese and lean heart failure patients: A case-control study with computational target prediction analysis

Gene

Volumn 574, Issue 1, 2015, Pages 1-10

  Thomé, Juliana Gil ^a   Mendoza, Mariana Recamonde ^b   Cheuiche, Amanda Veiga ^a,b   La Porta, Vanessa Laubert ^a,b   Silvello, Daiane ^a,b   dos Santos, Kátia Gonçalves ^a,b,c   Andrades, Michael Everton ^a,b   Clausell, Nadine ^a,b   Rohde, Luis Eduardo ^a,b   Biolo, Andréia ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

Adiposity; Heart failure; MicroRNA; Obesity; Target prediction

Indexed keywords

MICRORNA; MICRORNA 130B; MICRORNA 21; MICRORNA 221; MICRORNA 423 5P; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CONTROLLED STUDY; ENDOCRINE DISEASE; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HEART FAILURE; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTION; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; BIOLOGY; BLOOD; BODY WEIGHT; GENETICS; MIDDLE AGED; PROCEDURES;

BODY COMPOSITION; BODY MASS INDEX; CASE-CONTROL STUDIES; COMPUTATIONAL BIOLOGY; FEMALE; HEART FAILURE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OBESITY; THINNESS; WAIST CIRCUMFERENCE;

EID: 84943584023     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.07.068     Document Type: Article

References (60)

1. Alexander R., Lodish H., Sun L. MicroRNAs in adipogenesis and as therapeutic targets for obesity. Expert Opin. Ther. Targets 2011, 15:623-636.
2. Alexiou P., Maragkakis M., Papadopoulos G.L., Reczko M., Hatzigeorgiou A.G. Lost in translation: an assessment and perspective for computational microRNA target identification. Bioinformatics 2009, 25(23):3049-3055.
3. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455(7209):64-71.
4. Balaga O., Friedman Y., Linial M. Toward a combinatorial nature of microRNA regulation in human cells. Nucleic Acids Res. 2012, 40(19):9404-9416.
5. Bazil J.N., Stamm K.D., Li X., Thiagarajan R., Nelson T.J., Tomita-Mitchell A., et al. The inferred cardiogenic gene regulatory network in the mammalian heart. PLoS One 2014, 9(6):e100842.
6. Becker K.G., Barnes K.C., Bright T.J., Wang S.A. Genetic association database. Nat. Rev. Genet. 2004, 5:431.
7. Betel D., Wilson M., Gabow A., Marks D.S., Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008, 36(Suppl. 1):D149-D153.
8. Betel D., Koppal A., Agius P., Sander C., Leslie C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. 2010, 11(8):R90.
9. Bovolenta L.A., Acencio M.L., Lemke N. HTRIdb: an open-access database for experimentally verified human transcriptional regulation interactions. BMC Genomics 2012, 13:405.
10. Bujak M., Frangogiannis N. The role of TGF-β signaling in myocardial infarction and cardiac remodeling. Cardiovasc. Res. 2007, 74:184-195.
11. Chen X., Liang H., Zhang J., Zen K., Zhang C.Y. Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol. 2012, 22(3):125-132.
12. Cohen E.D., Tian Y., Morrisey E.E. Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development 2008, 135:789-798.
13. Cornier M.-A., Després J.-P., Davis N., Grossniklaus D.A., Klein S., Lamarche B., et al. Assessing adiposity: a scientific statement from the American Heart Association. Circulation 2011, 124:1996-2019.
14. Creemers E.E., Tijsen A.J., Pinto Y.M. Circulating microRNAs novel biomarkers and extracellular communicators in cardiovascular disease?. Circ. Res. 2012, 110(3):483-495.
15. Das S., Halushka M.K. Extracellular vesicle microRNA transfer in cardiovascular disease. Cardiovasc. Pathol. 2015, 24(4):199-206.
16. Enns J.E., Taylor C.G., Zahradka P. Variations in adipokine genes AdipoQ, Lep, and LepR are associated with risk for obesity-related metabolic disease: the modulatory role of gene-nutrient interactions. J. Obes. 2011, 2011. (Article ID 168659 17 pp.).
17. Fritz H.K., Lindgren D., Ljungberg B., Axelson H., Dahlbäck B. The miR21/10b ratio as a prognostic marker in clear cell renal cell carcinoma. Eur. J. Cancer 2014, 50:1758-1765.
18. Gehart H., Kumpf S., Ittner A., Ricci R. MAPK signalling in cellular metabolism: stress or wellness?. EMBO Rep. 2010, 11:834-840.
19. Goldraich L.A., Martinelli N.C., Matte U., Cohen C., Andrades M., Pimentel M., et al. Transcoronary gradient of plasma microRNA 423-5p in heart failure: evidence of altered myocardial expression. Biomarkers 2014, 2:135-141.
20. Goren Y., Kushnir M., Zafrir B., Tabak S., Lewis B.S., Amir O. Serum levels of microRNAs in patients with heart failure. Eur. J. Heart Fail. 2012, 14:147-154.
21. Gross D.N., van den Heuvel A.P., Birnbaum M.J. The role of FoxO in the regulation of metabolism. Oncogene 2008, 27:2320-2336.
22. Hsu S.D., Lin F.M., Wu W.Y., Liang C., Huang W.C., Chan W.L., et al. miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res. 2010, gkq1107.
23. Jeyaraja S.C., Ungera N.T., Chotania M.A. Rap1 GTPases: an emerging role in the cardiovasculature. Life Sci. 2011, 88:645-652.
24. Kanehisa M., Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000, 28:27-30.
25. Keller P., Gburcik V., Petrovic N., Gallagher I.J., Nedergaard J., Cannon B., Timmons J.A. Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity. BMC Endocr. Disord. 2011, 11:7.
26. Kilic I.D., Dodurga Y., Uludag B., Alihanoglu Y., Yildiz B.S., Enli Ym Secme M., Bostanci H.E. MicroRNA-143 and -223 in obesity. Gene 2015, 560:140-142.
27. Kumarswamy R., Thum T. Non-coding RNAs in cardiac remodeling and heart failure. Circ. Res. 2013, 113:676-689.
28. Larne O., Martens-Uzunova E., Hagman Z., Edsjö A., Lippolis G., Vredenbregt-van den Berg M.S., et al. miQ - a novel microRNA based diagnostic and prognostic tool for prostate cancer. Int. J. Cancer 2013, 132(12):2867-2875.
29. Lee E.K., Lee M.J., Abdelmohsen K., Kim W., Kim M.M., Srikantan S., et al. MiR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression. Mol. Cell. Biol. 2011, 31:626-638.
30. Levin J., Serlin C., Seaman A. A controlled, powerful multiple-comparison strategy for several situations. Psychol. Bull. 1994, 115:153-159.
31. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
32. Li J.H., Liu S., Zhou H., Qu L.H., Yang J.H. starBase v2. 0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2013, gkt1248.
33. -CT method. Methods 2001, 25:402-408.
34. Maeda M., Holder E., Lowes B., et al. Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin. Circulation 1997, 95:17-20.
35. Maragkakis M., Reczko M., Simossis V.A., Alexiou P., Papadopoulos G.L., Dalamagas T., et al. DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res. 2009, 37:W273-W276.
36. Meerson A., Traurig M., Ossowski V., Fleming J.M., Mullins M., Baier L.J. Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNFα. Diabetologia 2013, 56:1971-1979.
37. Musling A.J. MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin. Sci. (Lond.) 2008, 115:203-218.
38. Oreopoulos A., Padwal R., Kalantar-Zadeh K., Fonarow G., McAlister F. Body mass index and mortality in heart failure: a meta-analysis. Am. Heart J. 2008, 156:13-22.
39. Ortega F.J., Mercader J.M., Catalán V., Moreno-Navarrete J.M., Pueyo N., Sabater M., et al. Targeting the circulating microRNA signature of obesity. Clin. Chem. 2013, 59:781-792.
40. Pan S., Yang X., Jia Y., Li R., Zhao R. Microvesicle-shuttled miR-130b reduces fat deposition in recipient primary cultured porcine adipocytes by inhibiting PPAR-γ expression. J. Cell. Physiol. 2014, 229(5):631-639.
41. Pi-Sunyer F.X. Obesity: criteria and classification. Proc. Nutr. Soc. 2000, 59:505-509.
42. Proud C. Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy. Cardiovasc. Res. 2004, 63:403-413.
43. R Development Core Team R: A Language and Environment for Statistical Computing 2010, R Foundation for Statistical Computing, Vienna, Austria, (retrieve from http://www-R-project.org).
44. Rappaport N., Nativ N., Stelzer G., Twik M., Guan-Golan Y., Stein T.I. MalaCards: an integrated compendium for diseases and their annotation. Database 2013, bat018.
45. Roger V.L. Epidemiology of heart failure. Circ. Res. 2013, 113:646-659.
46. Ronnebaum S., Patterson C. The FoxO family in cardiac function and dysfunction. Annu. Rev. Physiol. 2010, 72:81-94.
47. Schinner S., Willenberg H.S., Schott M., Scherbaum W.A. Pathophysiological aspects of Wnt-signaling in endocrine disease. Eur. J. Endocrinol. 2009, 160:731-737.
48. Sethupathy P., Megraw M., Hatzigeorgiou A.G. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat. Methods 2006, 3(11):881-886.
49. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13(11):2498-2504.
50. Takenaka A., Nakamura S., Mitsunaga F., Inoue-Murayama M., Udono T., Suryobroto B. Human-specific SNP in obesity genes, adrenergic receptor Beta2 (ADRB2), Beta3 (ADRB3), and PPAR γ2 (PPARG), during primate evolution. PLoS One 2012, 7(8). e43461.
51. Tatsuguchi M., Seok H.Y., Callis T.E., Thomson J.M., Chen J.F., Newman M., et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J. Mol. Cell. Cardiol. 2007, 42:1137-1141.
52. Tijsen A.J., Creemers E.E., Moerland P.D., De Windt L.J., Van Der Wal A.C., Kok W.E., et al. MiR423-5p as a circulating biomarker for heart failure. Circ. Res. 2010, 106:1035-1039.
53. Topkara V.K., Mann D.L. Role of microRNAs in cardiac remodeling and heart failure. Cardiovasc. Drugs Ther. 2011, 25:171-182.
54. Vodovar N., Séronde M.F., Laribi S., Gayat E., Lassus J., Boukef R., et al. Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure. Eur. Heart J. 2014, 35(48):3434-3441.
55. Von Haehling S., Doehner W., Anker S.D. Revisiting the obesity paradox in heart failure: new insights?. Eur. J. Heart Fail. 2011, 13:130-132.
56. Wang J., Lu M., Qiu C., Cui Q. TransmiR: a transcription factor-microRNA regulation database. Nucleic Acids Res. 2010, 38:D119-D122.
57. Wang C., Wang S., Zhao P., Wang X., Wang J., Wang Y., et al. MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression. J. Cell. Biochem. 2012, 113:2040-2046.
58. Wen J.J., Zago M.P., Nunez S., Gupta S., Burgos F.N., Garg N.J. Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease. Mol. Cell. Proteomics 2012, 11(8):435-452.
59. Witkos T.M., Koscianska E., Krzyzosiak W.J. Practical aspects of microRNA target prediction. Curr. Mol. Med. 2011, 11(2):93-109.
60. Yang R., Barouch L. Leptin signaling and obesity: cardiovascular consequences. Circ. Res. 2007, 101:545-559.